TY - JOUR
T1 - Long-term recurrence-free survival in a patient with primary hepatic carcinosarcoma
T2 - Case report with a literature review
AU - Yamamoto, Yusuke
AU - Ojima, Hidenori
AU - Shimada, Kazuaki
AU - Onaya, Hiroaki
AU - Hiraoka, Nobuyoshi
AU - Mizuguchi, Yasunori
AU - Kosuge, Tomoo
AU - Kanai, Yae
N1 - Funding Information:
This work was supported in part by a grant-in-aid for Cancer Research from the Ministry of Health, Labor and Welfare and by a grant-in-aid for the Third-term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan.
PY - 2010/2
Y1 - 2010/2
N2 - A 72-year-old man was found to have a 40 mm mass in liver segment VIII during follow-up abdominal ultrasonography for type C viral hepatitis. Abdominal ultrasound showed a well-defined mass containing a cystic component, and computed tomographic hepatic arteriography showed heterogeneous enhancement except for cystic necrosis. Under a pre-operative diagnosis of atypical hepatocellular carcinoma (HCC), partial resection of liver segment VIII was performed. The encapsulated tumor consisted of a peripheral solid component with a central necrotic area. Histologically, the solid component had a two-layer structure, an HCC component in the external area and a sarcomatous component with neoplastic osteoid formation in the internal area, showing histological transition. Immunohistochemically, the HCC component was positive for hepatocyte antigen and negative for vimentin. The Ki-67 labeling index was found to increase from 5% to 58% with increasing histologic atypia. The sarcomatous component was positive for vimentin and negative for pan-keratin and hepatocyte antigen, with a Ki-67 labeling index of >90%. These findings led to a diagnosis of primary hepatic carcinosarcoma. Although previously reported patients with hepatic carcinosarcoma showed early metastasis with a very poor outcome, this patient has remained free of recurrence for 30 months, which is the longest recurrence-free survival time recorded for this type of cancer. Since relatively early-stage hepatic carcinosarcoma rarely seems to present as a small tumor showing a concentric growth pattern, we report this case with a review of the literature.
AB - A 72-year-old man was found to have a 40 mm mass in liver segment VIII during follow-up abdominal ultrasonography for type C viral hepatitis. Abdominal ultrasound showed a well-defined mass containing a cystic component, and computed tomographic hepatic arteriography showed heterogeneous enhancement except for cystic necrosis. Under a pre-operative diagnosis of atypical hepatocellular carcinoma (HCC), partial resection of liver segment VIII was performed. The encapsulated tumor consisted of a peripheral solid component with a central necrotic area. Histologically, the solid component had a two-layer structure, an HCC component in the external area and a sarcomatous component with neoplastic osteoid formation in the internal area, showing histological transition. Immunohistochemically, the HCC component was positive for hepatocyte antigen and negative for vimentin. The Ki-67 labeling index was found to increase from 5% to 58% with increasing histologic atypia. The sarcomatous component was positive for vimentin and negative for pan-keratin and hepatocyte antigen, with a Ki-67 labeling index of >90%. These findings led to a diagnosis of primary hepatic carcinosarcoma. Although previously reported patients with hepatic carcinosarcoma showed early metastasis with a very poor outcome, this patient has remained free of recurrence for 30 months, which is the longest recurrence-free survival time recorded for this type of cancer. Since relatively early-stage hepatic carcinosarcoma rarely seems to present as a small tumor showing a concentric growth pattern, we report this case with a review of the literature.
KW - Concentric growth pattern
KW - Hepatic carcinosarcoma
KW - Hepatocellular carcinoma
KW - Osteosarcoma
UR - http://www.scopus.com/inward/record.url?scp=77449156327&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77449156327&partnerID=8YFLogxK
U2 - 10.1093/jjco/hyp123
DO - 10.1093/jjco/hyp123
M3 - Article
C2 - 19801559
AN - SCOPUS:77449156327
SN - 0368-2811
VL - 40
SP - 166
EP - 173
JO - Japanese journal of clinical oncology
JF - Japanese journal of clinical oncology
IS - 2
M1 - hyp123
ER -